Cargando…

Immunocastration in Gilts: A Preliminary Study of the Effect of the Second Dose Administration Time on Growth, Reproductive Tract Development, and Carcass and Meat Quality

SIMPLE SUMMARY: Nowadays, a significant proportion of pig carcasses destined to high-quality dry-cured ham elaboration are declared unsuitable for this purpose. The main reason is the lack of backfat thickness, affecting females in particular because males are castrated. Moreover, the estrus in gilt...

Descripción completa

Detalles Bibliográficos
Autores principales: Pérez-Ciria, Leticia, Carcò, Giuseppe, Miana-Mena, Francisco Javier, Mitjana, Olga, Falceto, María Victoria, Latorre, Maria Angeles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919812/
https://www.ncbi.nlm.nih.gov/pubmed/33669212
http://dx.doi.org/10.3390/ani11020510
_version_ 1783658187449171968
author Pérez-Ciria, Leticia
Carcò, Giuseppe
Miana-Mena, Francisco Javier
Mitjana, Olga
Falceto, María Victoria
Latorre, Maria Angeles
author_facet Pérez-Ciria, Leticia
Carcò, Giuseppe
Miana-Mena, Francisco Javier
Mitjana, Olga
Falceto, María Victoria
Latorre, Maria Angeles
author_sort Pérez-Ciria, Leticia
collection PubMed
description SIMPLE SUMMARY: Nowadays, a significant proportion of pig carcasses destined to high-quality dry-cured ham elaboration are declared unsuitable for this purpose. The main reason is the lack of backfat thickness, affecting females in particular because males are castrated. Moreover, the estrus in gilts is undesirable because it carries out productive losses. Immunocastration could resolve these problems. The protocol of immunocastration in white-breed gilts is not well established, especially in terms of the second injection. Therefore, the objective of the current trial was to evaluate the impact of immunocastration and to determine the optimum time for the second dose application in gilts intended for dry-cured ham production. In this trial, we concluded that gilt immunocastration is positive, increasing carcass fatness and decreasing reproductive tract development. Moreover, the optimum time to administer the second dose of immunocastration for this type of gilt seems to be between 9 and 12 weeks before sacrifice. ABSTRACT: Increasing fatness and avoiding puberty are desirable in gilts intended for high-quality dry-cured ham production. A total of 48 Duroc x (Landrace x Large White) females of 26.5 ± 3.70 kg body weight (BW) were used to evaluate the impact of immunocastration and to find the optimum application time of the second dose for immunocastration on growth; sex hormones; reproductive tract development; and carcass, meat, and fat quality. Gilts were allocated to four experimental treatments (n = 12): control (entire gilts, EG) and immunocastrated gilts (IG), providing the second dose at 12, 9, or 7 weeks before slaughter (with approximately 60, 75, or 90 kg BW, respectively). Mean slaughter BW was 125 kg. Immunocastrated gilts had lighter reproductive tracts and greater fat thickness than EG. Fat from IG was more saturated and less polyunsaturated than that from EG. Numerically, gilts immunocastrated 9 and 12 weeks before slaughter presented higher fatness than those immunocastrated 7 weeks before slaughter. In conclusion, immunocastration is a good strategy to improve the fatness of gilts destined to dry-cured ham elaboration, with the optimum time for the second dose application seemingly between 9 and 12 weeks before slaughter.
format Online
Article
Text
id pubmed-7919812
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-79198122021-03-02 Immunocastration in Gilts: A Preliminary Study of the Effect of the Second Dose Administration Time on Growth, Reproductive Tract Development, and Carcass and Meat Quality Pérez-Ciria, Leticia Carcò, Giuseppe Miana-Mena, Francisco Javier Mitjana, Olga Falceto, María Victoria Latorre, Maria Angeles Animals (Basel) Article SIMPLE SUMMARY: Nowadays, a significant proportion of pig carcasses destined to high-quality dry-cured ham elaboration are declared unsuitable for this purpose. The main reason is the lack of backfat thickness, affecting females in particular because males are castrated. Moreover, the estrus in gilts is undesirable because it carries out productive losses. Immunocastration could resolve these problems. The protocol of immunocastration in white-breed gilts is not well established, especially in terms of the second injection. Therefore, the objective of the current trial was to evaluate the impact of immunocastration and to determine the optimum time for the second dose application in gilts intended for dry-cured ham production. In this trial, we concluded that gilt immunocastration is positive, increasing carcass fatness and decreasing reproductive tract development. Moreover, the optimum time to administer the second dose of immunocastration for this type of gilt seems to be between 9 and 12 weeks before sacrifice. ABSTRACT: Increasing fatness and avoiding puberty are desirable in gilts intended for high-quality dry-cured ham production. A total of 48 Duroc x (Landrace x Large White) females of 26.5 ± 3.70 kg body weight (BW) were used to evaluate the impact of immunocastration and to find the optimum application time of the second dose for immunocastration on growth; sex hormones; reproductive tract development; and carcass, meat, and fat quality. Gilts were allocated to four experimental treatments (n = 12): control (entire gilts, EG) and immunocastrated gilts (IG), providing the second dose at 12, 9, or 7 weeks before slaughter (with approximately 60, 75, or 90 kg BW, respectively). Mean slaughter BW was 125 kg. Immunocastrated gilts had lighter reproductive tracts and greater fat thickness than EG. Fat from IG was more saturated and less polyunsaturated than that from EG. Numerically, gilts immunocastrated 9 and 12 weeks before slaughter presented higher fatness than those immunocastrated 7 weeks before slaughter. In conclusion, immunocastration is a good strategy to improve the fatness of gilts destined to dry-cured ham elaboration, with the optimum time for the second dose application seemingly between 9 and 12 weeks before slaughter. MDPI 2021-02-16 /pmc/articles/PMC7919812/ /pubmed/33669212 http://dx.doi.org/10.3390/ani11020510 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pérez-Ciria, Leticia
Carcò, Giuseppe
Miana-Mena, Francisco Javier
Mitjana, Olga
Falceto, María Victoria
Latorre, Maria Angeles
Immunocastration in Gilts: A Preliminary Study of the Effect of the Second Dose Administration Time on Growth, Reproductive Tract Development, and Carcass and Meat Quality
title Immunocastration in Gilts: A Preliminary Study of the Effect of the Second Dose Administration Time on Growth, Reproductive Tract Development, and Carcass and Meat Quality
title_full Immunocastration in Gilts: A Preliminary Study of the Effect of the Second Dose Administration Time on Growth, Reproductive Tract Development, and Carcass and Meat Quality
title_fullStr Immunocastration in Gilts: A Preliminary Study of the Effect of the Second Dose Administration Time on Growth, Reproductive Tract Development, and Carcass and Meat Quality
title_full_unstemmed Immunocastration in Gilts: A Preliminary Study of the Effect of the Second Dose Administration Time on Growth, Reproductive Tract Development, and Carcass and Meat Quality
title_short Immunocastration in Gilts: A Preliminary Study of the Effect of the Second Dose Administration Time on Growth, Reproductive Tract Development, and Carcass and Meat Quality
title_sort immunocastration in gilts: a preliminary study of the effect of the second dose administration time on growth, reproductive tract development, and carcass and meat quality
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919812/
https://www.ncbi.nlm.nih.gov/pubmed/33669212
http://dx.doi.org/10.3390/ani11020510
work_keys_str_mv AT perezcirialeticia immunocastrationingiltsapreliminarystudyoftheeffectoftheseconddoseadministrationtimeongrowthreproductivetractdevelopmentandcarcassandmeatquality
AT carcogiuseppe immunocastrationingiltsapreliminarystudyoftheeffectoftheseconddoseadministrationtimeongrowthreproductivetractdevelopmentandcarcassandmeatquality
AT mianamenafranciscojavier immunocastrationingiltsapreliminarystudyoftheeffectoftheseconddoseadministrationtimeongrowthreproductivetractdevelopmentandcarcassandmeatquality
AT mitjanaolga immunocastrationingiltsapreliminarystudyoftheeffectoftheseconddoseadministrationtimeongrowthreproductivetractdevelopmentandcarcassandmeatquality
AT falcetomariavictoria immunocastrationingiltsapreliminarystudyoftheeffectoftheseconddoseadministrationtimeongrowthreproductivetractdevelopmentandcarcassandmeatquality
AT latorremariaangeles immunocastrationingiltsapreliminarystudyoftheeffectoftheseconddoseadministrationtimeongrowthreproductivetractdevelopmentandcarcassandmeatquality